← Open Payments lookup

WENDY FOULKROD: Open Payments

NPI 1720073752 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,978 in 93 payments from 16 companies in 2025. Trend: 2023 $1,223 · 2024 $1,264 · 2025 $1,978

Food & beverage: $1,879Education: $99
CompanyPaymentsAmount
ABBVIE INC.26$497
Janssen Biotech, Inc.9$301
Lilly USA, LLC9$239
PFIZER INC.19$216
Regeneron Healthcare Solutions, Inc.5$126
Janssen Scientific Affairs, LLC2$95
Takeda Pharmaceuticals U.S.A., Inc.3$79
Aimmune Therapeutics, Inc.3$73
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$72
Ipsen Biopharmaceuticals, Inc3$71

Products named: TREMFYA, RINVOQ, OMVOH, VELSIPITY, DUPIXENT, ZENPEP, XIFAXAN, MAVYRET.

Industry payments across WA — which companies pay providers there.